XML 57 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2017   169,893,324        
Beginning Balance at Dec. 31, 2017 $ 3,362,469 $ 1,699 $ 4,073,362 $ 0 $ (21,930) $ (690,662)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative-effect adjustment to accumulated deficit related to adoption of new accounting pronouncement (38,601)         (38,601)
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)   1,797,241        
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (44,601) $ 18 (44,619)      
Issuance of common stock under employee stock purchase plan (in shares)   543,520        
Issuance of common stock under employee stock purchase plan 25,768 $ 5 25,763      
Stock-based compensation 164,310   164,310      
Equity component of convertible senior notes, net of issuance costs 275,836   275,836      
Issuance of warrants related to convertible senior notes 119,945   119,945      
Purchase of note hedge related to convertible senior notes (261,740)   (261,740)      
Repurchases of common stock (in shares)   (8,347,366)        
Repurchases of common stock (625,925)     (625,925)    
Net income 204,358         204,358
Foreign currency translation adjustments         (26,047)  
Change in unrealized gain on investments, net of tax (242)       (241)  
Ending balance (in shares) at Sep. 30, 2018   163,886,719        
Ending Balance at Sep. 30, 2018 3,155,531 $ 1,722 4,352,857 (625,925) (48,218) (524,905)
Beginning balance (in shares) at Jun. 30, 2018   169,311,093        
Beginning Balance at Jun. 30, 2018 3,445,278 $ 1,718 4,303,531 (185,512) (41,971) (632,488)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)   470,224        
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (6,087) $ 4 (6,091)      
Stock-based compensation 55,417   55,417      
Repurchases of common stock (in shares)   (5,894,598)        
Repurchases of common stock (440,413)     (440,413)    
Net income 107,583         107,583
Foreign currency translation adjustments (7,771)       (7,771)  
Change in unrealized gain on investments, net of tax 1,524       1,524  
Ending balance (in shares) at Sep. 30, 2018   163,886,719        
Ending Balance at Sep. 30, 2018 3,155,531 $ 1,722 4,352,857 (625,925) (48,218) (524,905)
Beginning balance (in shares) at Dec. 31, 2018   162,904,550        
Beginning Balance at Dec. 31, 2018 3,191,860 $ 1,629 3,670,033 0 (48,912) (430,890)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative-effect adjustment to accumulated deficit related to adoption of new accounting pronouncement 851         851
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)   1,833,758        
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (59,635) $ 18 (59,653)      
Issuance of common stock under employee stock purchase plan (in shares)   473,462        
Issuance of common stock under employee stock purchase plan 27,669 $ 5 27,664      
Stock-based compensation 167,475   167,475      
Equity component of convertible senior notes, net of issuance costs 240,820   240,820      
Issuance of warrants related to convertible senior notes 185,150   185,150      
Purchase of note hedge related to convertible senior notes (312,225)   (312,225)      
Repurchases of common stock (in shares)   (3,552,268)        
Repurchases of common stock (291,788)     (291,788)    
Net income 358,935         358,935
Foreign currency translation adjustments (10,744)       (10,744)  
Change in unrealized gain on investments, net of tax 3,232       3,232  
Ending balance (in shares) at Sep. 30, 2019   161,659,502        
Ending Balance at Sep. 30, 2019 3,501,600 $ 1,652 3,919,264 (291,788) (56,424) (71,104)
Beginning balance (in shares) at Jun. 30, 2019   163,359,091        
Beginning Balance at Jun. 30, 2019 3,394,764 $ 1,649 3,760,840 (116,247) (42,484) (208,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (in shares)   305,367        
Issuance of common stock upon the exercise of stock options and vesting of restricted and deferred stock units, net of shares withheld for employee taxes (10,724) $ 3 (10,727)      
Stock-based compensation 55,406   55,406      
Equity component of convertible senior notes, net of issuance costs 240,820   240,820      
Issuance of warrants related to convertible senior notes 185,150   185,150      
Purchase of note hedge related to convertible senior notes (312,225)   (312,225)      
Repurchases of common stock (in shares)   (2,004,956)        
Repurchases of common stock (175,541)     (175,541)    
Net income 137,890         137,890
Foreign currency translation adjustments (14,095)       (14,095)  
Change in unrealized gain on investments, net of tax 155       155  
Ending balance (in shares) at Sep. 30, 2019   161,659,502        
Ending Balance at Sep. 30, 2019 $ 3,501,600 $ 1,652 $ 3,919,264 $ (291,788) $ (56,424) $ (71,104)